» Articles » PMID: 33803502

Nanomaterials for the Diagnosis and Treatment of Inflammatory Arthritis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Apr 3
PMID 33803502
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Nanomaterials have received increasing attention due to their unique chemical and physical properties for the treatment of rheumatoid arthritis (RA), the most common complex multifactorial joint-associated autoimmune inflammatory disorder. RA is characterized by an inflammation of the synovium with increased production of proinflammatory cytokines (IL-1, IL-6, IL-8, and IL-10) and by the destruction of the articular cartilage and bone, and it is associated with the development of cardiovascular disorders such as heart attack and stroke. While a number of imaging tools allow for the monitoring and diagnosis of inflammatory arthritis, and despite ongoing work to enhance their sensitivity and precision, the proper assessment of RA remains difficult particularly in the early stages of the disease. Our goal here is to describe the benefits of applying various nanomaterials as next-generation RA imaging and detection tools using contrast agents and nanosensors and as improved drug delivery systems for the effective treatment of the disease.

Citing Articles

Current Status of Gout Arthritis: Current Approaches to Gout Arthritis Treatment: Nanoparticles Delivery Systems Approach.

Herdiana Y, Wardhana Y, Kurniawansyah I, Gozali D, Wathoni N, Sofian F Pharmaceutics. 2025; 17(1).

PMID: 39861750 PMC: 11768112. DOI: 10.3390/pharmaceutics17010102.


Pain Management Strategies in Osteoarthritis.

Farinelli L, Riccio M, Gigante A, De Francesco F Biomedicines. 2024; 12(4).

PMID: 38672160 PMC: 11048725. DOI: 10.3390/biomedicines12040805.


Reprogramming Macrophage Polarization, Depleting ROS by Astaxanthin and Thioketal-Containing Polymers Delivering Rapamycin for Osteoarthritis Treatment.

Li H, Yuan Y, Zhang L, Xu C, Xu H, Chen Z Adv Sci (Weinh). 2023; 11(9):e2305363.

PMID: 38093659 PMC: 10916582. DOI: 10.1002/advs.202305363.


Nano - Based Therapeutic Strategies in Management of Rheumatoid Arthritis.

Nautiyal G, Sharma S, Kaushik D, Pandey P Recent Pat Nanotechnol. 2023; 18(4):433-456.

PMID: 37904559 DOI: 10.2174/1872210517666230822100324.


Receptors expressions on peripheral lymphocytes and CD4 CD183 as a diagnostics biomarker for rheumatoid arthritis: A case-control study in Ghana.

Sakyi S, Buckman T, Yeboah-Mensah K, Senu E, Effah A, Antwi-Berko D Immun Inflamm Dis. 2023; 11(8):e976.

PMID: 37647423 PMC: 10465995. DOI: 10.1002/iid3.976.


References
1.
Karpouzas G, Ormseth S, Hernandez E, Budoff M . Impact of Cumulative Inflammation, Cardiac Risk Factors, and Medication Exposure on Coronary Atherosclerosis Progression in Rheumatoid Arthritis. Arthritis Rheumatol. 2019; 72(3):400-408. DOI: 10.1002/art.41122. View

2.
Barani M, Nematollahi M, Zaboli M, Mirzaei M, Torkzadeh-Mahani M, Pardakhty A . In silico and in vitro study of magnetic niosomes for gene delivery: The effect of ergosterol and cholesterol. Mater Sci Eng C Mater Biol Appl. 2018; 94:234-246. DOI: 10.1016/j.msec.2018.09.026. View

3.
Hajizadeh M, Maleki H, Barani M, Fahmidehkar M, Mahmoodi M, Torkzadeh-Mahani M . cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents. Res Pharm Sci. 2019; 14(5):448-458. PMC: 6827193. DOI: 10.4103/1735-5362.268206. View

4.
Liu Y, Cao F, Sun B, Bellanti J, Zheng S . Magnetic nanoparticles: A new diagnostic and treatment platform for rheumatoid arthritis. J Leukoc Biol. 2020; 109(2):415-424. DOI: 10.1002/JLB.5MR0420-008RR. View

5.
Kopacz L, Ciosek Z, Gronwald H, Skomro P, Ardan R, Lietz-Kijak D . Comparative Analysis of the Influence of Selected Physical Factors on the Level of Pain in the Course of Temporomandibular Joint Disorders. Pain Res Manag. 2020; 2020:1036306. PMC: 7569428. DOI: 10.1155/2020/1036306. View